GV backs another spinout by MIT’s serial entrepreneur Feng Zhang as epigenetics becomes an emerging area of healthcare.

David Russell, an executive-in-residence at Oxford’s Saïd Business School, has been appointed chief executive of PraxisAuril, following in the footsteps of Maxine Ficarra.

Cambridge Enterprise, Cambridge Innovation Capital and University of Cambridge are joined by 100 signatories like AstraZeneca and Microsoft for the Innovate Cambridge initiative.

Teri Willey, whose long list of accomplishments includes founding Cambridge Enterprise, will step down in November this year to focus on other projects.

Sean Fielding has worked for University of Exeter for nearly three decades, during which time his board memberships included ATTP, SETsquared and PraxisAuril.

Maxine Ficarra has been with the organisation since its original incarnation of Praxis Courses and CEO since it became PraxisAuril in 2017.

Oxford Science Enterprises now has just over $1bn under management and already boasts a portfolio of more than 80 University of Oxford spinouts.

Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.